HIGH ANXIETY AND WORKLOAD
For those who survived the economic crisis and M&As, the resulting environment has created the challenges of increased workload
and high stress levels, according to the survey. As shown in Figure 2, a majority of respondents (67%) said their workload
has increased within the past year. "Business increase without staff increase," was the topmost possible cause for the increased
workload, followed by "staffing cuts" and "merger and acquisition."
Figure 2. Within the past year, has your workload increased or decreased?
Similarly, more than half of our respondents (58%) said their stress level has increased in the last year (Figure 3). Some
of the reasons cited for this include "business uncertainty," "management uncertainty," "inter-departmental conflicts," "negative
workplace attitudes," "more stringent procedures," and "lack of training and continuing education."
Figure 3. Within the past year, has your stress level at work increased?
For small companies, this stress is added by diminished financial support. "Venture investors, often the umbilical cord of
food/fuel for the industry, long provided the lifeblood for young biotechnology companies, but the model is more challenged
today," writes Steven G. Burrill, the CEO of Burrill and Company, in his column, Biotech Writes its New Playbook, in this issue. "In addition, because biotech companies are competing in an investment-constrained environment, they often
only have sufficient funds to complete one phase of a project successfully before building the capabilities required to move
their project through the next phase," writes Burrill.
"We have always been asked to do more with the same number of resources," says Rob Gronke, a principal investigator at Biogen
Idec. "In terms of stress, it depends on how you can handle change. Those who can't are stressed out more than others," he